These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 21108436)

  • 1. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
    Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.
    Jackson EM; Shaikh TH; Gururangan S; Jones MC; Malkin D; Nikkel SM; Zuppan CW; Wainwright LM; Zhang F; Biegel JA
    Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism.
    Gigante L; Paganini I; Frontali M; Ciabattoni S; Sangiuolo FC; Papi L
    Fam Cancer; 2016 Jan; 15(1):123-6. PubMed ID: 26342593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.
    Jackson EM; Sievert AJ; Gai X; Hakonarson H; Judkins AR; Tooke L; Perin JC; Xie H; Shaikh TH; Biegel JA
    Clin Cancer Res; 2009 Mar; 15(6):1923-30. PubMed ID: 19276269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
    Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
    Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional chondrosarcoma in a survivor of rhabdoid tumor: enlarging the spectrum of tumors associated with SMARCB1 germline mutations.
    Forest F; David A; Arrufat S; Pierron G; Ranchere-Vince D; Stephan JL; Clemenson A; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Dec; 36(12):1892-6. PubMed ID: 23154773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor.
    Bourdeaut F; Lequin D; Brugières L; Reynaud S; Dufour C; Doz F; André N; Stephan JL; Pérel Y; Oberlin O; Orbach D; Bergeron C; Rialland X; Fréneaux P; Ranchere D; Figarella-Branger D; Audry G; Puget S; Evans DG; Pinas JC; Capra V; Mosseri V; Coupier I; Gauthier-Villars M; Pierron G; Delattre O
    Clin Cancer Res; 2011 Jan; 17(1):31-8. PubMed ID: 21208904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome.
    Ammerlaan AC; Ararou A; Houben MP; Baas F; Tijssen CC; Teepen JL; Wesseling P; Hulsebos TJ
    Br J Cancer; 2008 Jan; 98(2):474-9. PubMed ID: 18087273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
    Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors.
    Smith MJ; Wallace AJ; Bowers NL; Eaton H; Evans DG
    Cancer Genet; 2014 Sep; 207(9):373-8. PubMed ID: 24933152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays.
    Takita J; Chen Y; Kato M; Ohki K; Sato Y; Ohta S; Sugita K; Nishimura R; Hoshino N; Seki M; Sanada M; Oka A; Hayashi Y; Ogawa S
    Cancer Sci; 2014 Mar; 105(3):258-64. PubMed ID: 24418192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutation.
    Janson K; Nedzi LA; David O; Schorin M; Walsh JW; Bhattacharjee M; Pridjian G; Tan L; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2006 Sep; 47(3):279-84. PubMed ID: 16261613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS).
    Kordes U; Bartelheim K; Modena P; Massimino M; Biassoni V; Reinhard H; Hasselblatt M; Schneppenheim R; Frühwald MC
    Pediatr Blood Cancer; 2014 May; 61(5):919-21. PubMed ID: 24123847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.
    Toth G; Zraly CB; Thomson TL; Jones C; Lapetino S; Muraskas J; Zhang J; Dingwall AK
    Genes Chromosomes Cancer; 2011 Jun; 50(6):379-88. PubMed ID: 21412926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
    Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
    Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
    Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.